Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: Disease mechanisms and pharmacological rescue
暂无分享,去创建一个
Milena Bellin | Christine L Mummery | Eric Schulze-Bahr | Guiscard Seebohm | Christian Freund | Boris Greber | Douwe E Atsma | D. Atsma | C. Mummery | E. Schulze-Bahr | G. Seebohm | Eva Wrobel | B. Greber | I. Piccini | A. Verkerk | D. Ward-van Oostwaard | C. Freund | Arie O Verkerk | C. d’Aniello | M. Bellin | Miao Zhang | Stefan Frank | Cristina D'Aniello | Dorien Ward-van Oostwaard | Ilaria Piccini | Miao Zhang | Jyoti Rao | Eva Wrobel | Stefan Frank | Jyoti Rao | Cristina d’Aniello
[1] M. Keating,et al. Molecular basis of the long-QT syndrome associated with deafness. , 1997, The New England journal of medicine.
[2] P. Coumel,et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome , 1997, Nature Genetics.
[3] H. R. Lu,et al. Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes. , 2013, Stem Cell Research.
[4] G. Gemme,et al. [RARE CARDIAC ARRYTHMIAS OF THE PEDIATRIC AGE. II. SYNCOPAL ATTACKS DUE TO PAROXYSMAL VENTRICULAR FIBRILLATION. (PRESENTATION OF 1ST CASE IN ITALIAN PEDIATRIC LITERATURE)]. , 1963, La Clinica pediatrica.
[5] U. Ravens,et al. Activation of Human ether-a-go-go-Related Gene Potassium Channels by the Diphenylurea 1,3-Bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) , 2006, Molecular Pharmacology.
[6] M. Carter,et al. A Regulatory Mechanism That Detects Premature Nonsense Codons in T-cell Receptor Transcripts in Vivo Is Reversed by Protein Synthesis Inhibitors in Vitro* , 1995, The Journal of Biological Chemistry.
[7] M Bitner-Glindzicz,et al. Jervell and Lange-Nielsen syndrome: a Norwegian perspective. , 1999, American journal of medical genetics.
[8] M. Pembrey,et al. Mutational spectrum in the cardioauditory syndrome of Jervell and Lange-Nielsen , 2000, Human Genetics.
[9] J. Saenen,et al. Molecular aspects of the congenital and acquired Long QT Syndrome: clinical implications. , 2008, Journal of molecular and cellular cardiology.
[10] G. Breithardt,et al. KCNE1 mutations cause Jervell and Lange-Nielsen syndrome , 1997, Nature Genetics.
[11] Salih Coşkun,et al. Romano-Ward sendromunda KCNQ1 geninde bir duplikasyon mutasyonu , 2015 .
[12] Joseph J. Babcock,et al. Modulation of hERG potassium channel gating normalizes action potential duration prolonged by dysfunctional KCNQ1 potassium channel , 2012, Proceedings of the National Academy of Sciences.
[13] B. Attali,et al. Structural Basis of Slow Activation Gating in the Cardiac IKs Channel Complex , 2011, Cellular Physiology and Biochemistry.
[14] A. Pfeufer,et al. Long QT Syndrome–Associated Mutations in KCNQ1 and KCNE1 Subunits Disrupt Normal Endosomal Recycling of IKs Channels , 2008, Circulation research.
[15] David A. Scott,et al. Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity , 2013, Cell.
[16] M. Bitner-Glindzicz,et al. A spectrum of functional effects for disease causing mutations in the Jervell and Lange-Nielsen syndrome. , 2001, Cardiovascular research.
[17] Bernhard M. Schuldt,et al. A bioinformatic assay for pluripotency in human cells , 2011, Nature Methods.
[18] A J Moss,et al. Spectrum of Mutations in Long-QT Syndrome Genes: KVLQT1, HERG, SCN5A, KCNE1, and KCNE2 , 2000, Circulation.
[19] Karl-Ludwig Laugwitz,et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. , 2010, New England Journal of Medicine.
[20] P. Lambiase,et al. Cellular mechanisms underlying the increased disease severity seen for patients with long QT syndrome caused by compound mutations in KCNQ1. , 2014, The Biochemical journal.
[21] Bba,et al. Clinical Aspects of Type-1 Long-QT Syndrome by Location, Coding Type, and Biophysical Function of Mutations Involving the KCNQ1 Gene , 2007, Circulation.
[22] S. Olesen,et al. The KCNQ1 potassium channel: from gene to physiological function. , 2005, Physiology.
[23] S. Priori,et al. CaV1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder Including Arrhythmia and Autism , 2004, Cell.
[24] Ward Oc. A NEW FAMILIAL CARDIAC SYNDROME IN CHILDREN. , 1964 .
[25] Lauri Toivonen,et al. The Jervell and Lange-Nielsen Syndrome: Natural History, Molecular Basis, and Clinical Outcome , 2006, Archives des maladies du coeur et des vaisseaux.
[26] Oscar Casis,et al. Mechanism of Action of a Novel Human ether-a-go-go-Related Gene Channel Activator , 2006, Molecular Pharmacology.
[27] B Attali,et al. A recessive C‐terminal Jervell and Lange‐Nielsen mutation of the KCNQ1 channel impairs subunit assembly , 2000, The EMBO journal.
[28] H. Nakauchi,et al. Development of Defective and Persistent Sendai Virus Vector , 2010, The Journal of Biological Chemistry.
[29] Stanley Nattel,et al. Innovative approaches to anti-arrhythmic drug therapy , 2006, Nature Reviews Drug Discovery.
[30] Shinsuke Yuasa,et al. Disease characterization using LQTS-specific induced pluripotent stem cells. , 2012, Cardiovascular research.
[31] Simona Casini,et al. Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome , 2013, The EMBO journal.
[32] Andrew J. Wilson,et al. Abnormal KCNQ1 trafficking influences disease pathogenesis in hereditary long QT syndromes (LQT1). , 2005, Cardiovascular research.
[33] Teng Hong Tan,et al. Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells. , 2013, International journal of cardiology.
[34] L. Arbour,et al. LQTS in Northern BC: homozygosity for KCNQ1 V205M presents with a more severe cardiac phenotype but with minimal impact on auditory function , 2014, Clinical genetics.
[35] Fred H. Gage,et al. Induced pluripotent stem cells: the new patient? , 2012, Nature Reviews Molecular Cell Biology.
[36] W. A. Murray,et al. Long QT syndrome during high-dose cisapride. , 1995, Archives of internal medicine.
[37] M. Janse,et al. Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. , 2004, Cardiovascular research.
[38] C. Mummery,et al. Pluripotent stem cell models of human heart disease. , 2013, Cold Spring Harbor perspectives in medicine.
[39] C. Mummery,et al. Cardiomyocytes Derived From Pluripotent Stem Cells Recapitulate Electrophysiological Characteristics of an Overlap Syndrome of Cardiac Sodium Channel Disease , 2012, Circulation.
[40] M. Franz,et al. Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange– Nielsen Syndrome , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[41] Thomas Meitinger,et al. Calmodulin Mutations Associated With Recurrent Cardiac Arrest in Infants , 2013, Circulation.
[42] L. Maquat. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics , 2004, Nature Reviews Molecular Cell Biology.
[43] A. Feinberg,et al. Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements , 1997, Nature Genetics.
[44] P. Kowey,et al. Increasing I(Ks) corrects abnormal repolarization in rabbit models of acquired LQT2 and ventricular hypertrophy. , 2002, American journal of physiology. Heart and circulatory physiology.
[45] O. C. Ward. A NEW FAMILIAL CARDIAC SYNDROME IN CHILDREN. , 1964, Journal of the Irish Medical Association.
[46] Shinya Yamanaka,et al. iPS cells: a game changer for future medicine , 2014, The EMBO journal.
[47] A. Brown,et al. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG , 1997, FEBS letters.
[48] G. Breithardt,et al. Life-threatening Arrhythmias Genotype-phenotype Correlation in the Long-qt Syndrome : Gene-specific Triggers for Genotype-phenotype Correlation in the Long-qt Syndrome Gene-specific Triggers for Life-threatening Arrhythmias , 2022 .
[49] T. Seufferlein,et al. Modelling Human Channelopathies Using Induced Pluripotent Stem Cells: A Comprehensive Review , 2013, Stem cells international.
[50] A. Jervell,et al. CONGENITAL DEAF‐MUTISM, FUNCTIONAL HEART DISEASE WITH PROLONGATION OF THE Q‐T INTERVAL, AND SUDDEN DEATH , 1999, American heart journal.
[51] Donald M Bers,et al. Screening Drug-Induced Arrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays , 2013, Circulation.
[52] A. Rivas,et al. Inner Ear Abnormalities in a Kcnq1 (Kvlqt1) Knockout Mouse: A Model of Jervell and Lange-Nielsen Syndrome , 2005, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.
[53] Michael J Ackerman,et al. Impact of genetics on the clinical management of channelopathies. , 2013, Journal of the American College of Cardiology.
[54] Robert Passier,et al. Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. , 2010, Stem cell research.
[55] A. Wilde,et al. IKs in heart and hearing, the ear can do with less than the heart. , 2013, Circulation. Cardiovascular genetics.
[56] Divya Rajamohan,et al. Current status of drug screening and disease modelling in human pluripotent stem cells , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.